RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
STFBX
Price
$97.46
Change
-$0.26 (-0.27%)
Updated
Oct 7 closing price
Net Assets
2.62B
Interact to see
Advertisement

RLBAX vs STFBX

Header iconRLBAX vs STFBX Comparison
Open Charts RLBAX vs STFBXBanner chart's image
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
State Farm Balanced
Price$97.46
Change-$0.26 (-0.27%)
VolumeN/A
Net Assets2.62B
RLBAX vs STFBX Comparison Chart in %
View a ticker or compare two or three
VS
RLBAX vs. STFBX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBAX is a Hold and STFBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. STFBX (2.62B). STFBX pays higher dividends than RLBAX: STFBX (2.13) vs RLBAX (1.10). RLBAX was incepted earlier than STFBX: RLBAX (23 years) vs STFBX (58 years). RLBAX (1.31) is less costly to investors than STFBX (0.18). RLBAX is a more actively managed with annual turnover of: 44.00 vs. STFBX (19.00). RLBAX (250) and STFBX (250) have matching initial minimum investment requirements. RLBAX annual gain was more profitable for investors over the last year : 9.12 vs. STFBX (5.09). RLBAX (38.04) and STFBX (37.24) have equivalent 5 years return.
RLBAXSTFBXRLBAX / STFBX
Total Expense Ratio1.310.14936%
Annual Report Gross Expense Ratio1.310.18728%
Fund Existence23 years58 years-
Gain YTD13.77012.068114%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets266B2.62B10,145%
Annual Yield % from dividends1.102.1352%
Returns for 1 year9.125.09179%
Returns for 3 years47.9838.62124%
Returns for 5 years38.0437.24102%
Returns for 10 years68.7278.4588%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group